About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Inspiratory Muscle Training and Asthma | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01727765

Inspiratory Muscle Training and Asthma

This is a pilot study which will assess the feasibility of a follow on main study. This study will examine the impact of inspiratory muscle training on quality of life, rescue drug medication usage, a...

Lead sponsor: University of Portsmouth•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Portsmouth

Collaborators

National Health Service, United Kingdom

Age

18 - 59 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Asthma Control Questionnaire score of ≥ 1.5
•10 mg or less of prednisolone (or equivalent) daily
•Aged 18 to 59 years inclusive
•Able to provide written informed consent

Exclusion Criteria

•Any significant heart or lung disease other than asthma including any previous history of pneumothorax
•Patients with a concomitant condition (including clinically relevant cardiovascular, hepatic, neurological, endocrine, or other major systemic disease) not controlled with treatment, making implementation of the protocol or interpretation of the study results difficult
•Women who are pregnant
•Forced expiratory volume in one second of less than 50% best or predicted
•A history of smoking 20 cigarettes a day for 20 years or more (or an equivalent amount)
•Undertaken a structured program of inspiratory muscle training within the past three months
•Currently a participant in another interventional study

Related studies

RECRUITINGPhase 2

A Phase IIb Trial of LQ036 in Poorly Controlled Asthma

NCT07589439 · Asthma

Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational Investigation

NCT07011394 · Diagnosis, Inflammation, and more

RECRUITINGPhase 3

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

NCT06023589 · Asthma

RECRUITINGPhase 2

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

NCT07323654 · Eosinophilic Asthma

RECRUITINGPhase 3

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

NCT06979323 · Asthma

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 25, 2019Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment16

Start dateFeb 2014

Last updatedOct 25, 2019

Condition

Locations shown

Respiratory Centre, Queen Alexandra Hospital, Cosham

Portsmouth, Hampshire

University of Portsmouth

Portsmouth, Hampshire

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 25, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions